Skip to main content
main-content
Top

15-05-2018 | Rheumatoid arthritis | Article

Long-term safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial

Genovese MC et al. J Rheumatol 2018. doi: 10.3899/jrheum.170344

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.3899/jrheum.170344

Related topics